AbbVie Inc. | Cash Flow

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,128
1,774
5,144
5,953
5,309
5,687
Depreciation, Depletion & Amortization
897
786
836
1,189
1,501
1,765
Other Funds
313
217
30
35
246
7,101
Funds from Operations
5,609
4,337
7,031
8,730
9,951
14,553
Changes in Working Capital
658
788
504
1,689
9
1,126
Net Operating Cash Flow
6,267
3,549
7,535
7,041
9,960
13,427
Capital Expenditures
491
612
532
479
529
Purchase/Sale of Investments
1,775
308
29
2,956
563
Net Investing Cash Flow
879
926
12,936
6,074
274
Cash Dividends Paid - Total
2,555
2,661
3,294
3,717
4,107
Issuance/Reduction of Debt, Net
601
12
16,441
5,519
3
Net Financing Cash Flow
3,442
3,293
5,752
3,928
5,512
Net Change in Cash
3,694
1,247
51
3,299
4,203
Free Cash Flow
5,776
2,937
7,003
6,562
9,431
Net Assets from Acquisitions
405
622
11,488
2,495
-
Other Sources
-
-
19
118
-
Change in Capital Stock
27
427
7,425
5,765
1,156
Exchange Rate Effect
10
577
300
338
29
Other Uses
-
-
964
262
308

About AbbVie

View Profile
Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.